An estimated 38,000 children in the United States have Crohn’s disease, according to the report. The indication of the drug as a pediatric treatment was based on a multicenter, randomized and double-blind phase three study.
Humira, from AbbVie, is designed for patients that do not respond adequately to corticosteroids or immunomodulators.
More articles on gastroenterology:
Mobile screenings for Barrett’s esophagus?
6 things to know about colonoscopy cost & what a reimbursement cut would mean
32 statistics on ASC accounts receivable
